Should You Take NMN With Food? What the Absorption Data Suggests

Every NMN trial you have read was run on an empty stomach

Irie and colleagues gave ten healthy men a single NMN capsule at 9am after an overnight fast. Water only for the next five hours. That is the study everyone cites for NMN absorption.

The 2026 sublingual crossover did the same thing. Fourteen men, a standardised 806 kcal dinner finished by 21:00, then nothing but water. The tablet was swallowed on a rinsed, empty stomach.

Yoshino's prediabetes trial, Igarashi's twelve-week study in men over 65, the dose-ranging work at 300 to 900 mg — fasted or unspecified, every one.

So there is no fed arm anywhere in the human NMN literature. Not a single trial has compared a dose taken with breakfast against the same dose taken before it.

That is worth pausing on. "Take NMN on an empty stomach" gets repeated as though it were a result. It is a description of how the trials were designed, which is a different thing entirely.

Five times the dose moves the marker by a quarter

Irie's ten men were split across three doses: 100, 250 and 500 mg. Roughly three or four people per group. Blood was sampled for five hours.

Plasma NMN itself barely moved. What rose were its downstream metabolites. Peak methylnicotinamide — MNA, the methylated form nicotinamide is converted to before excretion — came in at 253 nM, 292 nM and 316 nM across the three doses.

Five times the dose, about a quarter more marker. The standard deviations overlapped heavily and the groups were tiny, so treat the shape rather than the exact numbers.

Still, the shape matters for the food question. If a fivefold change in dose shifts the readout that little, a meal is not going to shift it much either.

Food matters most to molecules that need fat

NMN is a phosphorylated nucleotide. It dissolves readily in water and carries a negative charge at gut pH. Nothing about it wants bile salts or dietary fat.

Compare that with vitamin D, or astaxanthin, or the EPA and DHA in a fish oil capsule. Those are lipid-soluble. A meal containing fat measurably improves how much crosses the gut wall, which is why the label says to take them with food.

NMN has the opposite profile. You cannot dissolve something that is already dissolved.

What a meal can plausibly do to NMN is slower and duller. It delays gastric emptying, so any peak arrives later and lower. It dilutes the dose. It brings competing substrates to the same stretch of intestine.

None of that has been measured for NMN in a human. All three would blunt a peak rather than stop absorption.

The transporter argument is thinner than it sounds

You will see Slc12a8 cited in almost every "empty stomach" argument. Grozio and colleagues reported it in 2019 as a dedicated NMN transporter in the mouse small intestine. It was sodium-dependent, it moved NMN but not nicotinamide riboside, and it was upregulated in the aged mouse ileum.

Read that sentence again and note the word mouse.

Then note what happened next. Schmidt and Brenner published a formal rebuttal in the same journal, arguing that the analytical methods and transport data did not support NMN transport by Slc12a8. The dispute has never been settled.

So the mechanistic case for fasted dosing rests on a contested finding in a species that is not you. Sodium-dependence in particular gets stretched into dietary advice it cannot carry.

Build a protocol on that and you are three inferences deep before you have touched a human.

Most of your dose never arrives as NMN anyway

The sublingual crossover is the cleanest look at this. Fourteen men took 250 mg either swallowed or dissolved under the tongue, eight days apart, with blood drawn at five, fifteen, thirty and sixty minutes.

Blood NMN did not differ between routes. Neither did nicotinamide. Neither did NAD+ itself. The only difference was in the terminal catabolites 2PY and 4PY, which rose faster after sublingual dosing.

That tells you something awkward. Bypassing the gut entirely — which is what sublingual dosing is sold as doing — did not change how much intact NMN showed up in blood.

The explanation is enzymatic. CD73 strips the phosphate off NMN to make nicotinamide riboside. CD38 cleaves it to nicotinamide. Gut bacteria deamidate some of it into a different pathway altogether. By the time anything reaches your bloodstream, much of the dose has changed identity. We covered the same problem from the other direction in why NAD+ cannot be taken directly.

Does the pool still rise? Yes. Igarashi's twelve-week trial in 42 men aged 65 and over reported whole-blood NAD+ at 2.57 times baseline on 250 mg a day. The system works. It just does not work by delivering intact NMN to your cells, which is precisely the thing a meal would interfere with.

The resveratrol in the same capsule has a clearer answer

If you take NMN alone, the fed question has no evidence attached to it. If you take a combined NMN and trans-resveratrol product, one half of that capsule does have food data — and it points somewhere specific.

Vaz-da-Silva and colleagues ran 24 healthy subjects through a crossover of 400 mg trans-resveratrol, taken either after a high-fat meal or after an eight-hour fast. Peak concentration fell to 79% of the fasted value. Total exposure was essentially unchanged at 106%. Time to peak stretched from 0.5 hours to 2.0 hours.

la Porte's team found something sharper. Eight subjects took 2,000 mg twice daily to steady state. Against a standard breakfast, a high-fat breakfast cut both twelve-hour exposure and peak concentration by about 45%. Quercetin and alcohol did nothing either way.

The practical reading is narrow but usable. A normal breakfast costs you little. A fry-up costs you roughly half your resveratrol exposure.

That is the only food rule on this page with human numbers behind it. If you want the wider picture on why resveratrol is difficult to absorb at all, the BioPerine problem covers it.

If it upsets your stomach, food is the fix

Tolerability is where the fed question actually earns its keep.

Across the published trials, reported side effects are mild and mostly gastrointestinal. Irie's group found no significant adverse changes at any of the three doses. A separate four-week study reported that 1,250 mg a day was well tolerated in healthy adults.

But a capsule on an empty stomach is a familiar source of queasiness, and "mild" is not the same as "pleasant at 7am". If that is your experience, take it with breakfast.

You are not trading away a measured benefit. There is no measurement to trade. Our side effects review runs through what the trials actually recorded.

What to actually do

Pick the moment you will genuinely keep. Adherence is the variable with the largest effect size in any supplement protocol, and it is the only one fully under your control.

If your product contains trans-resveratrol, take it with an ordinary breakfast rather than a high-fat one. That is the single food-related decision with human data behind it.

If empty-stomach dosing makes you feel rough, take it with food and stop worrying about it.

Do not split the dose chasing absorption. Every trial cited here used a single daily dose, so single dosing is the option with evidence behind it, however thin. Timing rules follow the same logic — morning versus evening has exactly one trial behind it, and the evening placebo arm did rather well.

And keep the whole question in proportion. A 2024 meta-analysis pooled eight randomised trials in 342 middle-aged and older adults, at doses from 250 to 2,000 mg. It found no significant effect of NMN on fasting glucose, fasting insulin, HbA1c, insulin resistance or blood lipids. The strongest positive human result remains Yoshino's 25-woman trial, which reported a 25% rise in muscle insulin sensitivity by clamp in postmenopausal women with prediabetes.

That is the real state of the evidence. One encouraging small trial, a null pooled analysis, and an absorption literature with no fed arm in it. Arguing about breakfast is arguing about the third decimal place of something we have not yet measured to one. Our dosage guide covers the decisions that are worth more of your attention.

References

1. Irie, J., Inagaki, E., Fujita, M., Nakaya, H., Mitsuishi, M., Yamaguchi, S., et al. (2020). "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal, 67(2), 153-160. PMID 31685720.
2. Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. (2026). Scientific Reports, 16, 27464. DOI 10.1038/s41598-026-57552-9.
3. Grozio, A., Mills, K. F., Yoshino, J., Bruzzone, S., Sociali, G., Tokizane, K., et al. (2019). "Slc12a8 is a nicotinamide mononucleotide transporter." Nature Metabolism, 1(1), 47-57. DOI 10.1038/s42255-018-0009-4.
4. Schmidt, M. S., Brenner, C. (2019). "Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter." Nature Metabolism, 1(7), 660-661. DOI 10.1038/s42255-019-0085-0.
5. Igarashi, M., Nakagawa-Nagahama, Y., Miura, M., Kashiwabara, K., Yaku, K., Sawada, M., et al. (2022). "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." npj Aging, 8, 5. PMID 35927255.
6. Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., et al. (2021). "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science, 372(6547), 1224-1229. PMID 33888596.
7. Vaz-da-Silva, M., Loureiro, A. I., Falcao, A., Nunes, T., Rocha, J. F., Fernandes-Lopes, C., et al. (2008). "Effect of food on the pharmacokinetic profile of trans-resveratrol." International Journal of Clinical Pharmacology and Therapeutics, 46(11), 564-570. PMID 19000554.
8. la Porte, C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., Cameron, D. W. (2010). "Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects." Clinical Pharmacokinetics, 49(7), 449-454. PMID 20528005.
9. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. (2024). Critical Reviews in Food Science and Nutrition. PMID 39116016.
10. Airhart, S. E., Shireman, L. M., Risler, L. J., Anderson, G. D., Nagana Gowda, G. A., Raftery, D., et al. (2017). "An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers." PLoS ONE, 12(12), e0186459.

Take it with breakfast. Just know what is in it

Our NMN + Resveratrol lists 500 mg of NMN and 600 mg of trans-resveratrol per serving, with a batch certificate of analysis published for every run. No fed-versus-fasted claims, because nobody has run that trial.

See the Label and the CoA →